Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
1,344
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Fulgent Genetics Inc market cap is $673.89M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Fulgent Genetics Inc 52 week high is $31.04 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Fulgent Genetics Inc 52 week low is $13.46 as of November 22, 2026.
Fulgent Genetics Inc stock price today is $24.12.
Fulgent Genetics Inc stock price yesterday was $24.78.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Fulgent Genetics Inc's P/E ratio is -7.81.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Fulgent Genetics Inc P/B ratio is 0.6761.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Fulgent Genetics Inc 50-day moving average is $21.82.